Isracann Biosciences Inc. (CSE:IPOT) has launched its campaign on the Investing News Network’s cannabis channel.

Isracann is an Israel-based cannabis company focused on becoming a premier low-cost cannabis producer. The company is developing its fully-funded 230,000-square-foot cultivation facility near Tel Aviv, Israel, and plans to target the undersupplied domestic and European markets. The facility is being built to ISL and EU-GMP standards, and the company is applying for IMC-GAP and GSP certification, which allows Isracann to export its products and brands into Europe. Once Isracann’s facility is complete, it is expected to have an annual capacity of 23,500 kilograms.

Israel is high in humidity and has ideal year-round temperatures, allowing Isracann to keep its production rates as low as C$0.40 per gram. The country also receives, on average, 300 days of sun per year and high UV rays, which contributes to higher crop yields, more growing cycles and helps lower production costs.

Isracann’s company highlights include the following:

  • Isracann is focused on becoming a premier low-cost cannabis producer in Israel and the EU.
  • The European cannabis market is expected to be worth 123 billion euros by 2028.
  • Isracann is developing a fully-funded 230,000-square-foot cultivation facility near Tel Aviv.
  • Once complete, the facility can produce up to 23,500 kilograms of cannabis annually.
  • The facility is being built to EU-GMP standards, a necessity for exporting cannabis to the EU.
  • Isracann is also pursuing IMC-GAP and GSP certification for the facility to ensure that the company can export its products.
  • Israel offers an optimal environment to grow cannabis as it is high in humidity, has ideal temperatures and receives, on average, 300 days of sunshine.
  • The hybrid nature of Isracann’s cultivation facility allows the company to effectively utilize Israel’s climate, reducing production costs and increasing yields.
  • Isracann is targeting low-cost production at its facility at only C$0.40 per gram.

Click here to see the educational profile for Isracann Biosciences and to request an investor presentation. 

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less